ArticleThe oncologist2012

A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

Ji-An Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.